BFRG insider trading
NasdaqCM HealthcareBullFrog AI Holdings, Inc.: insider trade history from SEC Form 4 filings.
About BullFrog AI Holdings, Inc.
Bullfrog AI Holdings, Inc. operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform to analyze preclinical and clinical data for biotechnology and pharmaceutical companies, and other organizations. It also develops BF-222, a novel formulation of mebendazole , which is in the first phase for the treatment of Glioblastoma; BF-223, a novel prodrug of mebendazole, which is in the preclinical stage for the treatment of Glioblastoma; and BF-114, which is in the discovery phase, to treat obesity and chronic liver diseases. The company has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for use of a formulation of Mebendazole for the treatment of glioblastoma, and human cancer or neoplastic disease. It has a partnership with the Lieber Institute for Brain Development (LIBD) to enable the discovery and development of precision treatments for CNS disorders. The company was founded in 2017 and is headquartered in Gaithersburg, Maryland.
Company website: www.bullfrogai.com
BFRG insider activity at a glance
FilingIQ tracks 16 insider transactions for BFRG in filings since Apr 3, 2025. The most recent transaction is dated Sep 22, 2026.
Across the full history, 2 open-market purchases
and 5 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on BFRG insider trades is 66.8/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest BFRG Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Top insiders trading BFRG
Frequently asked
- How many insider trades does FilingIQ track for BFRG?
- FilingIQ tracks 16 Form 4 insider transactions for BFRG (BullFrog AI Holdings, Inc.), covering filings from Apr 3, 2025 onwards. 2 of those are dated within the last 90 days.
- Are BFRG insiders net buyers or net sellers?
- Across the full Form 4 history for BFRG, 2 transactions (13%) were open-market purchases and 5 (31%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does BFRG insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
- What sector is BFRG in?
- BullFrog AI Holdings, Inc. (BFRG) is classified in the Healthcare sector, specifically Health Information Services, with a current market capitalisation of $11.84M.
Methodology & sources
Every BFRG insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.